Palbociclib (PD 0332991) dihydrochloride is an orally active, selective inhibitor of CDK4 (IC50: 11 nM) and CDK6 (IC50: 16 nM), exhibiting anti-proliferative activity and inducing cell cycle arrest in HR-positive and HER2-negative breast cancers and hepatocellular carcinoma studies.
Molecular Weight:
520.45
Formula:
C24H31Cl2N7O2
Target:
CDK|||Others
* VAT and and shipping costs not included. Errors and price changes excepted
